Kevin Agatstein, CEO at Kaid Health
In 2023 I predict that unstructured medical data, which makes up the majority of a patient’s chart, will become too valuable to ignore by both providers and payers. Driven in part by the growth of Medicare Advantage and oncology, both of which require the data within medical notes rather than just claims and labs data, organizations will start to use their unstructured EMR data in entirely new ways.
Rob Cohen, CEO at Bamboo Health
In today’s
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Caris Life Sciences and ConcertAI Partner to Accelerate Drug Development and Novel Research
What You Should Know:
- Caris Life Sciences®(Caris), a molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, an oncology real-world evidence data and AI technology company, announced a unique partnership to align the two companies' oncology capabilities.
- The strategic partnership will create one of the largest translational and clinical
Read More
Real-World Data Startup Crescendo Health Launches with $3.2M
What You Should Know:
- Crescendo Health, a real-world data startup that's drastically reshaping how clinical researchers get access to hard-to-reach patient data to support their clinical research today officially announced its launch with $3.4M in seed funding from Define Ventures as well as the founders and CEOs of many other well-known organizations.
- Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand
Read More
Liver Cancer Awareness – Here’s What You Need to Know in 2023
By the end of 2022, nearly 42,00 new cases of primary liver cancer will be diagnosed in the United States. In fact, liver cancer incidence rates have more than tripled since 1980, marking an increased need for better detection and diagnosis.
We might not talk about liver cancer as much as we do breast or lung cancer, but it’s a real threat to millions of Americans – and we need to continue spreading awareness.
Early detection is especially critical in treating liver cancer.
Read More
C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy
What You Should Know:
- C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader.
- The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers.
- Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More
The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations and higher bars from Payers and PBMs.
Now, drug manufacturers are bucking up. According to the IQVIA Institute, the prescription abandonment rate has reached 27 percent, or $76 billion annually, in specialty drugs alone. This squandered revenue has led manufacturers to increase their focus on the complex, nuanced patient journey.
As a
Read More
The Evolution from Hearing Aids to Wellness Devices
Here’s what we know from decades of research: Hearing loss affects health and well-being, but people with hearing loss are often reluctant to wear hearing aids. Of course, they’re doing themselves no favors. But when they do finally opt for hearing assistance (on average, about seven years after they learn they need it), we also now know that the longer people wear hearing aids — throughout the day, for instance, rather than just in certain situations — the healthier they tend to be. Better
Read More
Real-World Study Uses AI to Identify Undiagnosed Dementia in Primary Care
What You Should Know:
- Rising to meet the formidable challenge of the timely diagnosis of dementia, research scientists from Regenstrief Institute, IUPUI and the medical schools of Indiana University and the University of Miami are conducting the Digital Detection of Dementia study, a real-world evaluation of the use of an artificial intelligence (AI) tool they developed for early identification of Alzheimer’s disease and related dementias in primary care, the setting where most adults
Read More
We’re Feeling the Effects of the Nursing Shortage. Health Tech Can Help
The healthcare industry is in desperate need of nurses — and fast. Chances are this isn't news to you. You've seen the countless headlines covering the impact the pandemic has had on nurses, and how that nursing shortage has impacted employment numbers, healthcare facilities, and patient care.
Nurses are burnt out. They're stressed, exhausted, and struggling to find adequate mental health support. But the pandemic isn't the only issue to blame. Experts are predicting that over 1 million RNs
Read More
Kahun Taps MediOrbis to Offer AI-Powered Digital Intake and Triage Services
What You Should Know:
- MediOrbis, a multi-specialty telehealth company today announces a strategic partnership with Kahun, the clinical reasoning tool that performs dynamic clinical assessments at scale.
- The strategic partnership will enable MediOrbis to offer Kahun’s proprietary AI-driven digital intake tool as a part of its comprehensive telehealth platform.
- By offering Kahun’s proprietary AI-driven digital intake tool as a part of its comprehensive
Read More